FANCD2 activates transcription of TAp63 and suppresses tumorigenesis

Eunmi Park1, Hyungjin Kim, Jung Min Kim

  • 1Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA.

Molecular Cell
|June 29, 2013
PubMed

Insights

Fanconi anemia (FA) patients have increased squamous cell cancer risk due to reduced FANCD2-Ub and TAp63. Usp1 inhibition may offer a strategy to boost TAp63 and prevent these cancers.

Area of Science:

  • Genetics
  • Cancer Biology
  • DNA Repair

Background:

  • Fanconi anemia (FA) is a rare genetic disorder linked to squamous cell cancer susceptibility.
  • FA proteins, including FANCD2, are crucial for DNA repair, with monoubiquitination of FANCD2 being a key step.
  • The mechanism by which FANCD2 monoubiquitination (FANCD2-Ub) prevents squamous cell cancers remains unclear.

Purpose of the Study:

  • To investigate the role of FANCD2 monoubiquitination in skin carcinogenesis.
  • To explore the relationship between Usp1, FANCD2-Ub, and the tumor suppressor TAp63.
  • To evaluate Usp1 inhibition as a potential therapeutic strategy for squamous cell cancers.

Main Methods:

  • Utilizing Fancd2-deficient and Usp1-deficient mouse models.
  • Analyzing Ras-oncogene-driven skin carcinogenesis.
  • Assessing TAp63 activation and cellular senescence.

Main Results:

  • Fancd2-deficient mice exhibited increased susceptibility to skin tumors.
  • Usp1-deficient mice, with high FANCD2-Ub levels, showed resistance to skin tumors.
  • FANCD2-Ub was found to activate TAp63 transcription, inducing cellular senescence and inhibiting tumor formation.

Conclusions:

  • Reduced FANCD2-Ub and TAp63 protein levels likely contribute to squamous cell cancer susceptibility in FA patients.
  • Usp1 inhibition emerges as a promising strategy for upregulating TAp63.
  • Targeting Usp1 could be a novel approach for preventing or treating squamous cell cancers in the general population.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...